Dextromethorphan Hydrobromide is a well known cough suppressant drug. During a research study jointly funded by the CIA and the US Navy, Dextromethorphan Hbr was established as a non-addictive substitute for Codeine, a common cough depressant. Codeine is an analgesic, which is addictive in nature. In 1958, the U.S. Food and Drug Administration approved this antitussive medicine as safe for use as a cough suppressant and minor throat/bronchial irritation – often caused by the flu and the common cold.
Uses of Dextromethorphan Hydrobromide
Recent developments suggest that Dextromethorphan Hydrobromide works as a placebo to offer relief for patients suffering from cough, the common cold, and the lack of sleep or difficulty sleeping due to upper respiratory infections. Dextromethorphan Hydrobromide lacks any physically addictive properties that might cause sedative side effects, so it is considered to be a relatively safe drug. This medicine has been reported as ineffective in curing cough in children. Additionally, the American Academy of Pediatrics has reported that Dextromethorphan Hydrobromide can act similarly to a placebo by acting as an effective cough suppressant for children suffering with cough symptoms and upper respiratory infections.
Dextromethorphan Hydrobromide as an Effective Cure for PBA
Recently, the U.S. Food and Drug Administration approved Dextromethorphan Hydrobromide 6700-34-1 as a potential treatment for patients suffering from pseudobulbar affect, also known as PBA. Pseudobulbar affect is a neurological disorder, which affects the emotional activity of the patient. The disease tends to cause the patient to laugh or cry involuntarily. PBA may occur as a secondary disease for various other neurological diseases or it may be a symptom of a brain injury. On October 29, 2010, the U.S. Food and Drug Administration approved a combination of dextromethorphan and a subtherapeutic dose of quinidine as a safe and effective cure for patients suffering from PBA.
Other Uses of Dextromethorphan Hydrobromide
Dextromethorphan Hydrobromide has also been identified as an effective medicine for patients suffering from amyotrophic lateral sclerosis and multiple sclerosis as it can assuage symptoms unproblematic crying and laughing. Given its non-addictive properties, the drug has also been established as a cure for the patients suffering with neuropathic pain while patients suffering from fibromyalgia may also use Dextromethorphan Hbr to alleviate crucial pain.
Dextromethorphan Hydrobromide as a Recreational Drug
Unfortunately, Dextromethorphan Hydrobromide has also been used as a recreational drug, which can be classified as a dissociative psychedelic drug. This drug can cause hallucinations that are similar to those caused by phencyclidine (PCP). If taken in higher dosages than the recommended amount, this drug can cause distortion of perception of one’s body, higher excitement, loss of ability to comprehend time, feelings of dissociation and exciting distortions in the visual field.
Current Research Studies
The National Institute of Drug Abuse (NIDA) is currently processing a research work to establish Dextromethorphan Hbr, Oxycodone and Gabapentin in combination as an efficient cure for Opioid-Induced Hyperalgesia.
In another research work of U.S. National Institute of Health, Abiraterone Acetate plus Prednisone Drug-Drug Interaction with Dextromethorphan and Theophylline are being tried as a possible treatment for Metastatic Castration-Resistant Prostate Cancer. The Institute is also studying the manner in which a human body suffering with cancer handles Dextromethorphan.
These research works are intended to establish the utility of Dextromethorphan as an aiding treatment for cancer patients.
LGM Pharma – Dextromethorphan Hydrobromide Supplier
LGM Pharma is a Dextromethorphan Hydrobromide supplier to the R&D and Compounding industry. As an active pharmaceutical ingredient supplier to some of the largest pharmaceutical companies, we support our clients throughout their entire critical path of drug development, from discovery to commercial production. Inquire about Dextromethorphan Hydrobromide prices, availability, delivery, purity and more.
*Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.